Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals.

Walker LM, Simek MD, Priddy F, Gach JS, Wagner D, Zwick MB, Phogat SK, Poignard P, Burton DR.

PLoS Pathog. 2010 Aug 5;6(8):e1001028. doi: 10.1371/journal.ppat.1001028.

2.

Antibody epitope exposure and neutralization of HIV-1.

Pantophlet R.

Curr Pharm Des. 2010;16(33):3729-43. Review.

PMID:
21128886
3.

Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses.

Pollara J, Bonsignori M, Moody MA, Pazgier M, Haynes BF, Ferrari G.

Curr HIV Res. 2013 Jul;11(5):378-87. Review.

4.

Virological features associated with the development of broadly neutralizing antibodies to HIV-1.

Moore PL, Williamson C, Morris L.

Trends Microbiol. 2015 Apr;23(4):204-11. doi: 10.1016/j.tim.2014.12.007. Epub 2015 Jan 5. Review.

5.

Roles of HIV-1 Env variable regions in viral neutralization and vaccine development.

Pinter A.

Curr HIV Res. 2007 Nov;5(6):542-53. Review.

PMID:
18045110
6.

HIV-1 envelope glycoprotein immunogens to induce broadly neutralizing antibodies.

Sliepen K, Sanders RW.

Expert Rev Vaccines. 2016;15(3):349-65. doi: 10.1586/14760584.2016.1129905. Epub 2016 Jan 8. Review.

PMID:
26654478
7.

Broadly Neutralizing Antibody-Guided Carbohydrate-Based HIV Vaccine Design: Challenges and Opportunities.

Liu CC, Zheng XJ, Ye XS.

ChemMedChem. 2016 Feb 17;11(4):357-62. doi: 10.1002/cmdc.201500498. Epub 2016 Jan 13. Review.

PMID:
26762799
8.

Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates.

Haynes BF, Montefiori DC.

Expert Rev Vaccines. 2006 Jun;5(3):347-63. Review.

9.

Neutralizing antibodies to HIV-1 induced by immunization.

McCoy LE, Weiss RA.

J Exp Med. 2013 Feb 11;210(2):209-23. doi: 10.1084/jem.20121827. Review.

10.

Structure-based vaccine design in HIV: blind men and the elephant?

Pejchal R, Wilson IA.

Curr Pharm Des. 2010;16(33):3744-53. Review.

11.

How HIV-1 entry mechanism and broadly neutralizing antibodies guide structure-based vaccine design.

Pancera M, Changela A, Kwong PD.

Curr Opin HIV AIDS. 2017 May;12(3):229-240. doi: 10.1097/COH.0000000000000360. Review.

PMID:
28422787
12.

Neutralizing antibodies against HIV-1: can we elicit them with vaccines and how much do we need?

Montefiori DC, Mascola JR.

Curr Opin HIV AIDS. 2009 Sep;4(5):347-51. doi: 10.1097/COH.0b013e32832f4a4d. Review.

13.

Specificity of the autologous neutralizing antibody response.

Moore PL, Gray ES, Morris L.

Curr Opin HIV AIDS. 2009 Sep;4(5):358-63. doi: 10.1097/COH.0b013e32832ea7e8. Review.

14.

Rational antibody-based HIV-1 vaccine design: current approaches and future directions.

Walker LM, Burton DR.

Curr Opin Immunol. 2010 Jun;22(3):358-66. doi: 10.1016/j.coi.2010.02.012. Epub 2010 Mar 17. Review.

15.

Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection.

Derdeyn CA, Moore PL, Morris L.

Curr Opin HIV AIDS. 2014 May;9(3):210-6. doi: 10.1097/COH.0000000000000057. Review.

16.

HIV broadly neutralizing antibody targets.

Wibmer CK, Moore PL, Morris L.

Curr Opin HIV AIDS. 2015 May;10(3):135-43. doi: 10.1097/COH.0000000000000153. Review.

17.

Antibody responses to envelope glycoproteins in HIV-1 infection.

Burton DR, Mascola JR.

Nat Immunol. 2015 Jun;16(6):571-6. doi: 10.1038/ni.3158. Review.

18.

Broadly Neutralizing Antibodies Against HIV: New Insights to Inform Vaccine Design.

Sadanand S, Suscovich TJ, Alter G.

Annu Rev Med. 2016;67:185-200. doi: 10.1146/annurev-med-091014-090749. Epub 2015 Nov 9. Review.

PMID:
26565674
19.

Broadly Neutralizing Antibodies for HIV Eradication.

Stephenson KE, Barouch DH.

Curr HIV/AIDS Rep. 2016 Feb;13(1):31-7. doi: 10.1007/s11904-016-0299-7. Review.

20.

Antibody polyspecificity and neutralization of HIV-1: a hypothesis.

Haynes BF, Moody MA, Verkoczy L, Kelsoe G, Alam SM.

Hum Antibodies. 2005;14(3-4):59-67. Review.

Supplemental Content

Support Center